CEPHEID - FY26 COVID AND STREP TESTING. REAL TIME POLYMER CHAIN REACTION (RT-PCR) ANALYZERS FOR BROOKE ARMY MEDICAL CENTER

PIID: W81K0025FA081

Signed Date: Dec 3, 2025Effective Date: Oct 1, 2025End Date: Closes in 113 days

Award $

$1.4M

Vendor

CEPHEID

NAICS

325413

Signed Date

Dec 3, 2025

Key Details

Dollars Obligated

$1.4M

Base & All Options

Awarding Agency

Department of Defense

Awarding Sub-Agency

Department of the Army

NAICS Code

325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Product Service Code

6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

JBSA FT SAM HOUSTON, TX, 782344400, CD-TX-21

Description

FY26 COVID AND STREP TESTING. REAL TIME POLYMER CHAIN REACTION (RT-PCR) ANALYZERS FOR BROOKE ARMY MEDICAL CENTER

Context & Analysis

On Dec 3, 2025, Department of Defense obligated $1,373,682.9 to CEPHEID for fy26 covid and strep testing. real time polymer chain reaction (rt-pcr) analyzers for brooke army medical center. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in JBSA FT SAM HOUSTON, TX. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.